News

Nasdaq4y
Sarepta Stock Gets Mixed Reviews From Analysts - Nasdaq
Sarepta Therapeutics (SRPT) is under Wall Street’s microscope right now.Shares dropped by 49% in a single session last week, following the release of disappointing clinical trial results ...
Investor's Business Daily on MSN11h
Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe
Sarepta Therapeutics' brutal week continued Friday after European officials rejected the company's controversial gene therapy ...
Business Insider1y
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report), AlloVir (ALVR – Research Report) and Bristol-Myers Squibb (BMY ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), Zimmer Biomet Holdings (ZBH) and Eli Lilly & Co (LLY)
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
Benzinga.com8mon
Sarepta Therapeutics Analyst Ratings and Price Targets | NASDAQ:SRPT ...
Explore Sarepta Therapeutics analyst ratings and price targets (NASDAQ:SRPT) on Benzinga. Stay updated on expert opinions and forecasts for SRPT stock.
Yahoo Finance4y
Sarepta Stock Gets Mixed Reviews From Analysts - Yahoo Finance
Sarepta Therapeutics (SRPT) is under Wall Street’s microscope right now.Shares dropped by 49% in a single session last week, following the release of disappointing clinical trial results ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), Illumina (ILMN) and Alpha Teknova (TKNO)
Detailed price information for Alpha Teknova Inc (TKNO-Q) from The Globe and Mail including charting and trades.